We aimed to investigate the prevalence of pulmonary thromboembolism (PTE) and its association with clinical variables in a cohort of hospitalized coronavirus disease 2019 (COVID-19) patients receiving low-molecular-weight heparin (LMWH) at prophylactic dosage.In this retrospective observational study we included COVID-19 patients receiving prophylactic LMWH from admission but still referred for lower-limbs venous Doppler ultrasound (LL-US) and computed tomography pulmonary angiography (CTPA) for clinical PTE suspicion. A dedicated radiologist reviewed CTPA images to assess PTE presence/extension.From March 1 to April 30, 2020, 45 patients were included (34 men, median age 67 years, interquartile range [IQR] 60-76). Twenty-seven (60%) had PTE signs at CTPA, 17/27 (63%) with bilateral involvement, none with main branch PTE. In 33/45 patients (73%) patients LL-US was performed before CTPA, with 3 patients having superficial vein thrombosis (9%, none with CTPA-confirmed PTE) and 1 patient having deep vein thrombosis (3%, with CTPA-confirmed PTE). Thirty-three patients (73%) had at least one comorbidity, mainly hypertension (23/45, 51%) and cardiovascular disease (15/45, 33%). Before CTPA, 5 patients had high D-dimer (11.21 μg/mL, IQR 9.10-13.02), 19 high fibrinogen (550 mg/dL, IQR 476-590), 26 high interleukin-6 (79 pg/mL, IQR 31-282), and 11 high C-reactive protein (9.60 mg/dL, IQR 6.75-10.65), C-reactive protein being the only laboratory parameter significantly differing between patients with and without PTE (P = .002)High PTE incidence (60%) in COVID-19 hospitalized patients under prophylactic LMWH could substantiate further tailoring of anticoagulation therapy.
Pulmonary thromboembolism in coronavirus disease 2019 patients undergoing thromboprophylaxis / S. Schiaffino, F. Giacomazzi, A. Esseridou, A. Cozzi, S. Carriero, D.P. Mazzaccaro, G. Nano, G. Di Leo, P. Spagnolo, F. Sardanelli. - In: MEDICINE. - ISSN 0025-7974. - 100:1(2021 Jan 08), pp. e24002.1-e24002.5.
|Titolo:||Pulmonary thromboembolism in coronavirus disease 2019 patients undergoing thromboprophylaxis|
COZZI, ANDREA (Corresponding)
SARDANELLI, FRANCESCO (Ultimo)
|Parole Chiave:||Aged; Anticoagulants; COVID-19; Computed Tomography Angiography; Female; Heparin, Low-Molecular-Weight; Hospitalization; Humans; Incidence; Male; Prevalence; Pulmonary Embolism; Retrospective Studies; Risk Factors; Ultrasonography, Doppler; Venous Thromboembolism; Thrombolytic Therapy|
|Settore Scientifico Disciplinare:||Settore MED/36 - Diagnostica per Immagini e Radioterapia|
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
Settore MED/17 - Malattie Infettive
|Data di pubblicazione:||8-gen-2021|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1097/MD.0000000000024002|
|Appare nelle tipologie:||01 - Articolo su periodico|
File in questo prodotto:
|Schiaffino et al. - 2021 - Pulmonary thromboembolism in coronavirus disease 2019 patients undergoing thromboprophylaxis.pdf||Articolo principale||Publisher's version/PDF||Open Access Visualizza/Apri|